Publications


2019

Determinants of Mammographic Density Change.

Azam S, Sjölander A, Eriksson M, Gabrielson M, Czene K, Hall P.


JNCI Cancer Spectr.
201902
https://www.ncbi.nlm.nih.gov/pubmed/31360892

Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening.

He W, Eriksson L, Törnberg S, Strand F, Hall P, Czene K.


BMC Med.
201901
https://pubmed.ncbi.nlm.nih.gov/30700300

Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer.

Eriksson L, He W, Eriksson M, Humphreys K, Bergh J, Hall P, Czene K.


JNCI Cancer Spectr.
201901
https://www.ncbi.nlm.nih.gov/pubmed/31360886

Shared heritability and functional enrichment across six solid cancers.

Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, et al.


Nat Commun.
201901
https://www.ncbi.nlm.nih.gov/pubmed/30683880

Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study.

Strand F, Azavedo E, Hellgren R, Humphreys K, Eriksson M, Shepherd J, Hall P, Czene K.


Breast Cancer Res.
201901
https://pubmed.ncbi.nlm.nih.gov/30670066

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, Andrulis IL, Anton-Culver H, Antonenkova NN, et al.


Am J Hum Genet.
201901
https://pubmed.ncbi.nlm.nih.gov/30554720

2018

Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer.

Li J, Humphreys K, Ho PJ, Eriksson M, Darai-Ramqvist E, Lindström LS, Hall P, Czene K.


JNCI Cancer Spectr.
201812
https://www.ncbi.nlm.nih.gov/pubmed/31360866

Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer

Marike Gabrielson, Kumari Ubhayasekera, Bo Ek, Mikael Andersson Franko,Mikael Eriksson, Kamila Czene, Jonas Bergquist, Per Hall


JNCI Cancer Spectrum
201811
https://www.ncbi.nlm.nih.gov/pubmed/31360875

In vivo measurement of the effective atomic number of breast skin using spectral mammography.

Berggren K, Eriksson M, Hall P, Wallis MG, Fredenberg E.


Phys Med Biol.
201810
https://www.ncbi.nlm.nih.gov/pubmed/30375362

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast.

Gabrielson M, Chiesa F, Behmer C, Rönnow K, Czene K, Hall P.


Breast Cancer Res Treat
201808
https://www.ncbi.nlm.nih.gov/pubmed/29603032

Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.

Taylor C, McGale P, Brønnum D, Correa C, Cutter D, Duane FK, Gigante B, Jensen MB, Lorenzen E, Rahimi K, Wang Z, Darby SC, Hall P, Ewertz M.


J Clin Oncol
201808
https://www.ncbi.nlm.nih.gov/pubmed/29791285

Identification of nine new susceptibility loci for endometrial cancer.

O’Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, Chang-Claude J, Chanock SJ, et al.


Nat Commun
201808
https://www.ncbi.nlm.nih.gov/pubmed/30093612

Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study.

Borgquist S, Rosendahl AH, Czene K, Bhoo-Pathy N, Dorkhan M, Hall P, Brand JS.


Breast Cancer Res
201808
https://www.ncbi.nlm.nih.gov/pubmed/30092829

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.

Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, Al-Ejeh F, Rozali E, Wang Q, Dennis J, Li B, Zeng C, Feng H, Gusev A, Barfield RT, Andrulis IL, et al.


Nat Genet
201807
https://www.ncbi.nlm.nih.gov/pubmed/29915430

A comprehensive tool for measuring mammographic density changes over time.

Eriksson M, Li J, Leifland K, Czene K, Hall P


Breast Cancer Res Treat
201806
https://www.ncbi.nlm.nih.gov/pubmed/29392583

The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.

Colombo M, Lòpez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meindl A, Montagna M, Niederacher D, et al.


Hum Mutat.
201805
https://www.ncbi.nlm.nih.gov/pubmed/29460995

Common genetic variation and novel loci associated with volumetric mammographic density.

Brand JS, Humphreys K, Li J, Karlsson R, Hall P, Czene K.


Breast Cancer Res
201804
https://www.ncbi.nlm.nih.gov/pubmed/29665850

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.

Rudolph A, Song M, Brook MN, Milne RL, Mavaddat N, Michailidou K, Bolla MK, Wang Q, Dennis J, Wilcox AN, Hopper JL, Southey MC, Keeman R, Fasching PA, Beckmann MW, et al.


Int J Epidemiol
201804
https://www.ncbi.nlm.nih.gov/pubmed/29315403

Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.

Strand F, Humphreys K, Holm J, Eriksson M, Törnberg S, Hall P, Azavedo E, Czene K.


Breast Cancer Res.
201804
https://www.ncbi.nlm.nih.gov/pubmed/29669579

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density.

Byström S, Eklund M, Hong MG, Fredolini C, Eriksson M, Czene K, Hall P, Schwenk JM, Gabrielson M.


Breast Cancer Res
201802
https://www.ncbi.nlm.nih.gov/pubmed/29444691